Cochlear and its competitor have both been belted a few times due to issues with there devices . It’s ugly when there is a question mark all of a sudden on a companies main product . Having said that I’m not sure what happened to cochlear main competitor but they definitely caused some concern for cochlear holders over the years only for there product to cause health issues in recipients and that was a massive win for cochlear . Again get it right and it blue sky .
EMvision Research Notes, page-2292
-
- There are more pages in this discussion • 390 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add EMV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.10 |
Change
-0.040(1.87%) |
Mkt cap ! $179.5M | |||
| Open | High | Low | Value | Volume |
| $2.10 | $2.15 | $2.10 | $72.21K | 34.03K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 2499 | $2.10 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.15 | 227 | 1 |
View Market Depth
| Last trade - 16.10pm 17/09/2024 (20 minute delay) ? |
| EMV (ASX) Chart |